| Literature DB >> 866794 |
W F Whitmore, A Smith, A Yagoda, S T Cvitkovic, R Golbey.
Abstract
1. Seminoma may occasionally be rapidly growing, aggressive, radioresistant, and chemotherapy-resistant tumor. 2. Alkylating agents have had the greatest number of trials and have produced the best response rates in the management of seminoma, but a wide range of other agents warrants trials. 3. Adjunct chemotherapy is a logical consideration in patients with stage II and stage III seminoma.Entities:
Mesh：
Substances：
Year: 1977 PMID： 866794 DOI： 10.1007/978-3-642-81095-4_27
Source DB: PubMed Journal: Recent Results Cancer Res ISSN： 0080-0015